The fact that no changes were observed in normoinsulinemic PCOS again clearly supports the hypothesis that not all obese PCOS patients are the same in terms of the dynamics of insulin secretion, sensitivity and degradation
Carrying extra body weight can result in various health complications, including but not limited to heart disease, type 2 diabetes, hypertension, arthritis, and specific forms of cancer
Focus: GLP-1 receptor agonists, semaglutide, and diabetic eye disease Goal: Help patients and families understand benefits, risks, and when retinal monitoring matters most Evidence-Based: Preferred Practice Patterns Standards of Care Systematic Reviews Meta-Analyses Diabetic Eye Disease Knowledge Hub Start with the complete guide: Diabetic Eye Disease: The Complete Patient Guide Quick Navigation What Are GLP-1 Drugs
Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, not involved in this research, explained what this means for people taking GLP-agonists